emocha miDOT

Maunank Shah

miDOT is a smartphone-based proxy for Directly Observed Therapy (DOT). miDOT allows patients to securely report side effects and submit videos of themselves taking medication for clinicians to review.

Product description

miDOT is a smartphone-based proxy for Directly Observed Therapy (DOT). miDOT allows patients to securely report side effects and submit videos of themselves taking medication for clinicians to review.

Target region(s)

U.S (Maryland, TexasCalifornia), Australia, India

Market suggested retail price

Free.

Competitive landscape
SDG targeted

Provide treatment to over 9 million people worldwide that are infected with tuberculosis. Tuberculosis treatment standards require healthcare workers to directly observe patients taking medication

Target user(s)

TB patients, clinicians.

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F